Virpax Pharmaceuticals, Inc. financial statements
Virpax Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2024
| Revenue | USD 0 | EODHD |
| Net income | −USD 12.07M | EODHD |
| Cash and equivalents | USD 1.51M | EODHD |
Virpax Pharmaceuticals, Inc. financials on 6ix · Virpax Pharmaceuticals, Inc. on 6ix